Task: Answer the multiple-choice question.
Question: Which drug exhibits a 12.980\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a S=C(Nc1ccc(Cl)cc1)N(CCCN1CCOCC1)Cc1cccs1
b COC(=O)c1cc(C(=O)OCC(=O)NNC(=O)c2cccs2)cc([N+](=O)[O-])c1
c COc1ccc(NC(=O)/C=C/c2ccc(S(=O)(=O)N3CCOCC3)cc2)cc1
d Cc1ccc(OCCCC(=O)NCc2ccco2)c(C)c1
e Cc1ccc(OCCNc2cc(N3CCN(CCO)CC3)ccc2[N+](=O)[O-])cc1C
Answer: e. Cc1ccc(OCCNc2cc(N3CCN(CCO)CC3)ccc2[N+](=O)[O-])cc1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(OCCNc2cc(N3CCN(CCO)CC3)ccc2[N+](=O)[O-])cc1C
Cc1ccc(OCCNc2cc(N3CCN(CCO)CC3)ccc2[N+](=O)[O-])cc1C
2-[4-[3-[2-(3,4-dimethylphenoxy)ethylamino]-4-nitrophenyl]piperazin-1-yl]ethanol